Global Financial Private Client, LLC Alkermes Plc. Transaction History
Global Financial Private Client, LLC
- $267 Billion
- Q4 2024
A detailed history of Global Financial Private Client, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Global Financial Private Client, LLC holds 7 shares of ALKS stock, worth $203. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7Holding current value
$203% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ALKS
# of Institutions
364Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$846 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$551 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$378 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$368 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$267 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.77B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...